ESTEEM TOTALLY IMPLANTABLE HEARING SYSTEM
Envoy Medical Corporation · Decision date Mar 17, 2010
What did the FDA approve?
FDA records P090018 as an original PMA application. The recorded decision is approval, dated Mar 17, 2010.
FDA approval order statement
APPROVAL FOR THE ESTEEM. THE ESTEEM IS INTENDED TO ALLEVIATE HEARING LOSS IN PATIENTS BY REPLICATING THE OSSICULAR CHAIN AND PROVIDING ADDITIONAL GAIN. THE ESTEEM IS INDICATED FOR PATIENTS WITH HEARING LOSS THAT MEET THE FOLLOWING CRITERIA: 1) 18 YEARS OF AGE OR OLDER;2) STABLE BILATERAL SENSORINEURAL HEARING LOSS;3) MODERATE TO SEVERE SENSORINEURAL HEARING LOSS DEFINED BY PURE TONE AVERAGE (PTA);4) UNAIDED SPEECH DISCRIMINATION TEST SCORE GREATER THAN OR EQUAL TO 40%;5) NORMALLY FUNCTIONING EUSTACHIAN TUBE;6) NORMAL MIDDLE EAR ANATOMY;7) NORMAL TYMPANIC MEMBRANE;8) ADEQUATE SPACE FOR ESTEEM IMPLANT DETERMINED VIA A HIGH RESOLUTION CT SCAN; AND9) MINIMUM 30 DAYS OF EXPERIENCE WITH APPROPRIATELY FIT HEARING AIDS.
- Regulatory pathway
- Original PMA
- Clinical specialty
- Ear, Nose, Throat
- Decision date
- Mar 17, 2010
Regulatory record facts
- Identifier
- P090018
- Regulatory pathway
- Premarket approval application
- Applicant
- Envoy Medical Corporation
- Product code
- OAF
- Decision code
- APPR
- Decision date
- Mar 17, 2010
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Implant, hearing, active, middle ear, totally implanted.
- Applicant
- Envoy Medical Corporation
- Product code
- OAF
- FDA device class
- 3
The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.
FDA decision timeline
P090018 received
Application receipt date recorded by FDA.
P090018 · FDA decision
APPR
Timeline entries are records held by MedtechLedger for P090018. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P090018
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
EsteemP090018/S044 | Envoy Medical Corporation | PMA supplement | Oct 15, 2026 | FDA |
Regulatory context
An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Envoy Medical Corporation
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 4875 White Bear Pkwy., White Bear Lake, MN, 55110
Sources and methodology
- Original FDA record: P090018
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records